Edwards Lifesciences (EW) EBITDA Margin Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 146.00 |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 54.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 264.00 |
| Mar 31, 2026 | 102.00 |
| Dec 31, 2025 | -1,293.00 |
| Sep 30, 2025 | -611.00 |
| Jun 30, 2025 | 7.00 |
| Mar 31, 2025 | 170.00 |
| Dec 31, 2024 | -483.00 |
| Sep 30, 2024 | -354.00 |
| Jun 30, 2024 | 616.00 |
| Mar 31, 2024 | -556.00 |
| Dec 31, 2023 | -1,860.00 |
| Sep 30, 2023 | -108.00 |
| Jun 30, 2023 | -1,284.00 |
| Mar 31, 2023 | -91.00 |
| Dec 31, 2022 | 1,783.00 |
| Sep 30, 2022 | 72.00 |
| Jun 30, 2022 | -595.00 |
| Mar 31, 2022 | 119.00 |
| Dec 31, 2021 | -133.00 |
| Sep 30, 2021 | -157.00 |